Evaluation of the clinical efficacy of mammotome minimally invasive rotary cutting surgery in the treatment of benign breast tumors: a comparative study.

Benign breast tumors, while noncancerous, can cause significant distress and necessitate efficient treatment methods. Mammotome minimally invasive rotary cutting surgery has emerged as a potential alternative to traditional approaches, promising reduced invasiveness and improved outcomes. This retrospective study, conducted from January 2022 to December 2023 at Ezhou Central Hospital, involved a comparative analysis between two groups: the observation group, treated with Mammotome minimally invasive rotary cutting surgery, and the control group, treated with conventional surgical methods. Key parameters assessed included surgical duration, intraoperative blood loss, incision healing time, hospital stay duration, postoperative complication rates, cosmetic outcomes, and changes in postoperative inflammatory and immune markers (TNF-α, hs-CRP, CD3 + , CD4 + /CD8 + ratios). Statistical significance was determined using appropriate tests, with p values less than 0.05 considered significant. The observation group demonstrated significantly better outcomes in terms of shorter surgical duration, reduced intraoperative blood loss, quicker incision healing, and shorter hospital stays compared to the control group (p < 0.05). In addition, the occurrence of postoperative complications was lower, and the rate of maintaining a good breast shape was higher in the observation group (p < 0.05). The observation group also showed lower levels of postoperative inflammatory markers (TNF-α, hs-CRP) and higher immune markers (CD3 + , CD4 + /CD8 + ratios) post-surgery (p < 0.05). Mammotome minimally invasive rotary cutting surgery is an effective and preferable method for the treatment of benign breast tumors, offering reduced surgical trauma, faster recovery, fewer complications, better cosmetic outcomes, and more favorable postoperative inflammatory and immune responses compared to traditional surgical methods. Despite the retrospective design, the findings suggest that Mammotome surgery may serve as a standard approach in benign breast tumor management, with further prospective research needed to validate these outcomes.